nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—PDE4B—bipolar disorder	0.794	1	CbGaD
Amlexanox—IL3—blood plasma—bipolar disorder	0.0216	0.315	CbGeAlD
Amlexanox—FGF1—blood plasma—bipolar disorder	0.00632	0.0922	CbGeAlD
Amlexanox—S100A13—thyroid gland—bipolar disorder	0.00363	0.0529	CbGeAlD
Amlexanox—S100A13—nervous system—bipolar disorder	0.00305	0.0445	CbGeAlD
Amlexanox—S100A13—cerebellum—bipolar disorder	0.00287	0.0419	CbGeAlD
Amlexanox—PDE4D—thyroid gland—bipolar disorder	0.00239	0.0348	CbGeAlD
Amlexanox—S100A13—brain—bipolar disorder	0.00233	0.034	CbGeAlD
Amlexanox—S100A12—brain—bipolar disorder	0.0023	0.0336	CbGeAlD
Amlexanox—PDE4C—nervous system—bipolar disorder	0.00228	0.0333	CbGeAlD
Amlexanox—FGF1—thyroid gland—bipolar disorder	0.00223	0.0326	CbGeAlD
Amlexanox—PDE4A—thyroid gland—bipolar disorder	0.00211	0.0308	CbGeAlD
Amlexanox—PDE4D—cerebellum—bipolar disorder	0.00189	0.0276	CbGeAlD
Amlexanox—FGF1—nervous system—bipolar disorder	0.00188	0.0274	CbGeAlD
Amlexanox—FGF1—cerebellum—bipolar disorder	0.00177	0.0258	CbGeAlD
Amlexanox—PDE4C—brain—bipolar disorder	0.00174	0.0254	CbGeAlD
Amlexanox—PDE4A—cerebellum—bipolar disorder	0.00167	0.0244	CbGeAlD
Amlexanox—PDE4D—brain—bipolar disorder	0.00154	0.0224	CbGeAlD
Amlexanox—FGF1—brain—bipolar disorder	0.00144	0.0209	CbGeAlD
Amlexanox—PDE4A—brain—bipolar disorder	0.00136	0.0198	CbGeAlD
Amlexanox—PDE4B—thyroid gland—bipolar disorder	0.00126	0.0184	CbGeAlD
Amlexanox—PDE4B—nervous system—bipolar disorder	0.00106	0.0155	CbGeAlD
Amlexanox—PDE4B—cerebellum—bipolar disorder	0.000998	0.0145	CbGeAlD
Amlexanox—PDE4B—brain—bipolar disorder	0.00081	0.0118	CbGeAlD
Amlexanox—FGF1—Innate Immune System—ADCY2—bipolar disorder	0.000102	0.000748	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—ADM—bipolar disorder	0.000102	0.000741	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—TAC1—bipolar disorder	0.000101	0.000736	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—ADCY2—bipolar disorder	0.000101	0.000734	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—GSK3B—bipolar disorder	0.0001	0.000731	CbGpPWpGaD
Amlexanox—IL3—Immune System—NRG1—bipolar disorder	0.0001	0.000731	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—GSK3B—bipolar disorder	0.0001	0.00073	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—DRD3—bipolar disorder	9.99e-05	0.000729	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—DRD2—bipolar disorder	9.95e-05	0.000726	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—TSHB—bipolar disorder	9.89e-05	0.000722	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—TACR1—bipolar disorder	9.89e-05	0.000722	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—HTR2C—bipolar disorder	9.89e-05	0.000722	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—DRD1—bipolar disorder	9.89e-05	0.000722	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—HTR2A—bipolar disorder	9.88e-05	0.000721	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—AKR1C4—bipolar disorder	9.86e-05	0.00072	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—HTR1A—bipolar disorder	9.85e-05	0.000719	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—DGKH—bipolar disorder	9.8e-05	0.000716	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—HTR1A—bipolar disorder	9.75e-05	0.000712	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—DRD4—bipolar disorder	9.7e-05	0.000708	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TAC1—bipolar disorder	9.7e-05	0.000708	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—TAC1—bipolar disorder	9.6e-05	0.000701	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—DRD3—bipolar disorder	9.58e-05	0.000699	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—DRD1—bipolar disorder	9.51e-05	0.000694	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—HTR2C—bipolar disorder	9.51e-05	0.000694	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—DRD5—bipolar disorder	9.42e-05	0.000688	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—HTR2C—bipolar disorder	9.41e-05	0.000687	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—DRD1—bipolar disorder	9.41e-05	0.000687	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—HTR1A—bipolar disorder	9.3e-05	0.000679	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—DRD4—bipolar disorder	9.3e-05	0.000679	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—NTRK2—bipolar disorder	9.25e-05	0.000676	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—RGS4—bipolar disorder	9.24e-05	0.000674	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—DRD3—bipolar disorder	9.21e-05	0.000673	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—AKR1C4—bipolar disorder	9.19e-05	0.000671	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—GSK3A—bipolar disorder	9.17e-05	0.00067	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—TAC1—bipolar disorder	9.16e-05	0.000669	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—ADCY2—bipolar disorder	9.13e-05	0.000667	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—DRD3—bipolar disorder	9.12e-05	0.000666	CbGpPWpGaD
Amlexanox—S100A12—Immune System—S100B—bipolar disorder	9.09e-05	0.000664	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—DGKH—bipolar disorder	9.07e-05	0.000662	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—DRD2—bipolar disorder	9.04e-05	0.00066	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—HTR1A—bipolar disorder	9.02e-05	0.000658	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—HTR2C—bipolar disorder	8.98e-05	0.000656	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—DRD1—bipolar disorder	8.98e-05	0.000656	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—DRD5—bipolar disorder	8.97e-05	0.000655	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—DRD4—bipolar disorder	8.94e-05	0.000653	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—S100B—bipolar disorder	8.92e-05	0.000651	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—TAC1—bipolar disorder	8.88e-05	0.000648	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—HTR1A—bipolar disorder	8.85e-05	0.000646	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—DRD4—bipolar disorder	8.85e-05	0.000646	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—RGS4—bipolar disorder	8.79e-05	0.000642	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—ADCY2—bipolar disorder	8.75e-05	0.000639	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—TAC1—bipolar disorder	8.72e-05	0.000636	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—DRD1—bipolar disorder	8.71e-05	0.000636	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—HTR2C—bipolar disorder	8.71e-05	0.000636	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—DRD3—bipolar disorder	8.7e-05	0.000635	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—POMC—bipolar disorder	8.69e-05	0.000634	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—DRD2—bipolar disorder	8.66e-05	0.000632	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—HTR2C—bipolar disorder	8.55e-05	0.000624	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—DRD1—bipolar disorder	8.55e-05	0.000624	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—DGKH—bipolar disorder	8.46e-05	0.000617	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—DRD4—bipolar disorder	8.44e-05	0.000616	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—DRD3—bipolar disorder	8.44e-05	0.000616	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—ADCY2—bipolar disorder	8.42e-05	0.000615	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TCF7L2—bipolar disorder	8.39e-05	0.000612	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—DRD2—bipolar disorder	8.33e-05	0.000608	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—ADCY2—bipolar disorder	8.33e-05	0.000608	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—DRD5—bipolar disorder	8.3e-05	0.000606	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—DRD3—bipolar disorder	8.28e-05	0.000604	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—DRD2—bipolar disorder	8.24e-05	0.000602	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TRPC3—bipolar disorder	8.2e-05	0.000599	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—HTR1A—bipolar disorder	8.19e-05	0.000598	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—DRD4—bipolar disorder	8.19e-05	0.000598	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—RGS4—bipolar disorder	8.14e-05	0.000594	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—TAC1—bipolar disorder	8.07e-05	0.000589	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—DRD4—bipolar disorder	8.04e-05	0.000587	CbGpPWpGaD
Amlexanox—S100A12—Immune System—NRG1—bipolar disorder	8.02e-05	0.000586	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—ADCY2—bipolar disorder	7.95e-05	0.00058	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—DRD1—bipolar disorder	7.91e-05	0.000577	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—HTR2C—bipolar disorder	7.91e-05	0.000577	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—POMC—bipolar disorder	7.89e-05	0.000576	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—NRG1—bipolar disorder	7.87e-05	0.000575	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—DRD2—bipolar disorder	7.87e-05	0.000574	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—ADM—bipolar disorder	7.82e-05	0.000571	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—DRD5—bipolar disorder	7.73e-05	0.000565	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—ADCY2—bipolar disorder	7.71e-05	0.000563	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—DRD3—bipolar disorder	7.66e-05	0.000559	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—DRD2—bipolar disorder	7.63e-05	0.000557	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TACR1—bipolar disorder	7.62e-05	0.000557	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PDE4B—bipolar disorder	7.62e-05	0.000557	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TSHB—bipolar disorder	7.62e-05	0.000557	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RGS4—bipolar disorder	7.59e-05	0.000554	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—ADCY2—bipolar disorder	7.57e-05	0.000552	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—NRG1—bipolar disorder	7.56e-05	0.000552	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—NTRK1—bipolar disorder	7.54e-05	0.000551	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—DRD2—bipolar disorder	7.49e-05	0.000547	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—DRD4—bipolar disorder	7.44e-05	0.000543	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—S100B—bipolar disorder	7.33e-05	0.000535	CbGpPWpGaD
Amlexanox—IL3—Immune System—GSK3B—bipolar disorder	7.27e-05	0.000531	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TRPC3—bipolar disorder	7.14e-05	0.000521	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—ADCY2—bipolar disorder	7e-05	0.000511	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—HTR2A—bipolar disorder	6.97e-05	0.000509	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—DRD2—bipolar disorder	6.93e-05	0.000506	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—ADM—bipolar disorder	6.81e-05	0.000497	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TRPC3—bipolar disorder	6.79e-05	0.000496	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PDE4B—bipolar disorder	6.64e-05	0.000485	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TSHB—bipolar disorder	6.64e-05	0.000485	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TACR1—bipolar disorder	6.64e-05	0.000485	CbGpPWpGaD
Amlexanox—FGF1—Immune System—GSK3A—bipolar disorder	6.5e-05	0.000474	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—ADM—bipolar disorder	6.48e-05	0.000473	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—NRG1—bipolar disorder	6.47e-05	0.000473	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—HTR2A—bipolar disorder	6.33e-05	0.000462	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TACR1—bipolar disorder	6.32e-05	0.000461	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TSHB—bipolar disorder	6.32e-05	0.000461	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PDE4B—bipolar disorder	6.32e-05	0.000461	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—HTR1A—bipolar disorder	6.31e-05	0.000461	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TRPC3—bipolar disorder	6.29e-05	0.000459	CbGpPWpGaD
Amlexanox—FGF1—Immune System—HLA-E—bipolar disorder	6.23e-05	0.000455	CbGpPWpGaD
Amlexanox—FGF1—Disease—SNAP25—bipolar disorder	6.22e-05	0.000454	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TAC1—bipolar disorder	6.21e-05	0.000454	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—HTR2C—bipolar disorder	6.09e-05	0.000445	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—DRD1—bipolar disorder	6.09e-05	0.000445	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—HTR2A—bipolar disorder	6.07e-05	0.000443	CbGpPWpGaD
Amlexanox—FGF1—Disease—GSK3A—bipolar disorder	6e-05	0.000438	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ADM—bipolar disorder	6e-05	0.000438	CbGpPWpGaD
Amlexanox—FGF1—Immune System—ADCY2—bipolar disorder	5.96e-05	0.000435	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NTRK2—bipolar disorder	5.93e-05	0.000433	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—DRD3—bipolar disorder	5.9e-05	0.000431	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—GSK3A—bipolar disorder	5.88e-05	0.000429	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TRPC3—bipolar disorder	5.86e-05	0.000428	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TSHB—bipolar disorder	5.84e-05	0.000427	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TACR1—bipolar disorder	5.84e-05	0.000427	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—HTR2A—bipolar disorder	5.83e-05	0.000426	CbGpPWpGaD
Amlexanox—S100A12—Immune System—GSK3B—bipolar disorder	5.82e-05	0.000425	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—HTR2A—bipolar disorder	5.77e-05	0.000422	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—DRD4—bipolar disorder	5.73e-05	0.000418	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—GSK3B—bipolar disorder	5.71e-05	0.000417	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ADM—bipolar disorder	5.59e-05	0.000408	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—POMC—bipolar disorder	5.57e-05	0.000406	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—HTR2A—bipolar disorder	5.51e-05	0.000402	CbGpPWpGaD
Amlexanox—FGF1—Disease—ADCY2—bipolar disorder	5.51e-05	0.000402	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—HTR1A—bipolar disorder	5.49e-05	0.000401	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—GSK3B—bipolar disorder	5.49e-05	0.000401	CbGpPWpGaD
Amlexanox—FGF1—Disease—TCF7L2—bipolar disorder	5.49e-05	0.000401	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TSHB—bipolar disorder	5.45e-05	0.000398	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PDE4B—bipolar disorder	5.45e-05	0.000398	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TACR1—bipolar disorder	5.45e-05	0.000398	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TAC1—bipolar disorder	5.41e-05	0.000395	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—ADCY2—bipolar disorder	5.39e-05	0.000394	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TCF7L2—bipolar disorder	5.37e-05	0.000392	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL1B—bipolar disorder	5.35e-05	0.000391	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—HTR2A—bipolar disorder	5.34e-05	0.00039	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—DRD2—bipolar disorder	5.34e-05	0.00039	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—DRD1—bipolar disorder	5.31e-05	0.000387	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—HTR2C—bipolar disorder	5.31e-05	0.000387	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—HTR2A—bipolar disorder	5.24e-05	0.000383	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—HTR1A—bipolar disorder	5.23e-05	0.000382	CbGpPWpGaD
Amlexanox—FGF1—Immune System—S100B—bipolar disorder	5.19e-05	0.000379	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NTRK2—bipolar disorder	5.16e-05	0.000377	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TAC1—bipolar disorder	5.15e-05	0.000376	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—DRD3—bipolar disorder	5.14e-05	0.000375	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—GSK3A—bipolar disorder	5.12e-05	0.000374	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—POMC—bipolar disorder	5.05e-05	0.000369	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—HTR2C—bipolar disorder	5.05e-05	0.000369	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—DRD1—bipolar disorder	5.05e-05	0.000369	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—DRD4—bipolar disorder	4.99e-05	0.000364	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NTRK2—bipolar disorder	4.91e-05	0.000359	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—DRD3—bipolar disorder	4.89e-05	0.000357	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—GSK3A—bipolar disorder	4.87e-05	0.000356	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—HTR2A—bipolar disorder	4.85e-05	0.000354	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—POMC—bipolar disorder	4.85e-05	0.000354	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—HTR1A—bipolar disorder	4.84e-05	0.000353	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NTRK1—bipolar disorder	4.83e-05	0.000353	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TAC1—bipolar disorder	4.76e-05	0.000348	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—DRD4—bipolar disorder	4.75e-05	0.000347	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—GSK3B—bipolar disorder	4.7e-05	0.000343	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—S100B—bipolar disorder	4.7e-05	0.000343	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—ADCY2—bipolar disorder	4.7e-05	0.000343	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TCF7L2—bipolar disorder	4.68e-05	0.000342	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—DRD1—bipolar disorder	4.67e-05	0.000341	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—HTR2C—bipolar disorder	4.67e-05	0.000341	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—POMC—bipolar disorder	4.66e-05	0.00034	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—DRD2—bipolar disorder	4.65e-05	0.000339	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—INS—bipolar disorder	4.63e-05	0.000338	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—POMC—bipolar disorder	4.61e-05	0.000337	CbGpPWpGaD
Amlexanox—FGF1—Immune System—NRG1—bipolar disorder	4.58e-05	0.000335	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NTRK2—bipolar disorder	4.55e-05	0.000332	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—DRD3—bipolar disorder	4.53e-05	0.00033	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—HTR1A—bipolar disorder	4.51e-05	0.000329	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—GSK3A—bipolar disorder	4.51e-05	0.000329	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—ADCY2—bipolar disorder	4.47e-05	0.000326	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TCF7L2—bipolar disorder	4.45e-05	0.000325	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TAC1—bipolar disorder	4.44e-05	0.000324	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—DRD2—bipolar disorder	4.42e-05	0.000323	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—POMC—bipolar disorder	4.4e-05	0.000321	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—DRD4—bipolar disorder	4.39e-05	0.000321	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—DRD1—bipolar disorder	4.36e-05	0.000318	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—HTR2C—bipolar disorder	4.36e-05	0.000318	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL1B—bipolar disorder	4.29e-05	0.000313	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—POMC—bipolar disorder	4.27e-05	0.000312	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NTRK2—bipolar disorder	4.24e-05	0.000309	CbGpPWpGaD
Amlexanox—FGF1—Disease—NRG1—bipolar disorder	4.23e-05	0.000309	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—DRD3—bipolar disorder	4.22e-05	0.000308	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NTRK1—bipolar disorder	4.21e-05	0.000307	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—GSK3A—bipolar disorder	4.2e-05	0.000307	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—POMC—bipolar disorder	4.19e-05	0.000306	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NRG1—bipolar disorder	4.15e-05	0.000303	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ADCY2—bipolar disorder	4.14e-05	0.000302	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TCF7L2—bipolar disorder	4.12e-05	0.000301	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—DRD4—bipolar disorder	4.1e-05	0.000299	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—DRD2—bipolar disorder	4.09e-05	0.000299	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—S100B—bipolar disorder	4.09e-05	0.000299	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NTRK1—bipolar disorder	4e-05	0.000292	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—S100B—bipolar disorder	3.89e-05	0.000284	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—POMC—bipolar disorder	3.88e-05	0.000283	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ADCY2—bipolar disorder	3.86e-05	0.000282	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TCF7L2—bipolar disorder	3.84e-05	0.000281	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—DRD2—bipolar disorder	3.82e-05	0.000279	CbGpPWpGaD
Amlexanox—FGF1—Disease—MTHFR—bipolar disorder	3.81e-05	0.000278	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—HTR2A—bipolar disorder	3.74e-05	0.000273	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NTRK1—bipolar disorder	3.71e-05	0.000271	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NRG1—bipolar disorder	3.61e-05	0.000264	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—S100B—bipolar disorder	3.6e-05	0.000263	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NTRK1—bipolar disorder	3.45e-05	0.000252	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NRG1—bipolar disorder	3.44e-05	0.000251	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—S100B—bipolar disorder	3.36e-05	0.000245	CbGpPWpGaD
Amlexanox—FGF1—Immune System—GSK3B—bipolar disorder	3.33e-05	0.000243	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—HTR2A—bipolar disorder	3.25e-05	0.000238	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NRG1—bipolar disorder	3.18e-05	0.000232	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—HTR2A—bipolar disorder	3.1e-05	0.000226	CbGpPWpGaD
Amlexanox—FGF1—Disease—GSK3B—bipolar disorder	3.07e-05	0.000224	CbGpPWpGaD
Amlexanox—FGF1—Disease—INS—bipolar disorder	3.03e-05	0.000221	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—GSK3B—bipolar disorder	3.01e-05	0.00022	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—POMC—bipolar disorder	2.99e-05	0.000218	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—INS—bipolar disorder	2.97e-05	0.000217	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NRG1—bipolar disorder	2.96e-05	0.000216	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—HTR2A—bipolar disorder	2.87e-05	0.000209	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—HTR2A—bipolar disorder	2.67e-05	0.000195	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—GSK3B—bipolar disorder	2.62e-05	0.000191	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—POMC—bipolar disorder	2.6e-05	0.00019	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—INS—bipolar disorder	2.58e-05	0.000189	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—GSK3B—bipolar disorder	2.49e-05	0.000182	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—POMC—bipolar disorder	2.47e-05	0.000181	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—INS—bipolar disorder	2.46e-05	0.00018	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL1B—bipolar disorder	2.45e-05	0.000179	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—GSK3B—bipolar disorder	2.31e-05	0.000168	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—POMC—bipolar disorder	2.29e-05	0.000167	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—INS—bipolar disorder	2.28e-05	0.000166	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—GSK3B—bipolar disorder	2.15e-05	0.000157	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—POMC—bipolar disorder	2.13e-05	0.000156	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—INS—bipolar disorder	2.12e-05	0.000155	CbGpPWpGaD
